Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-PVVR vs ROFECOXIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-PVVR vs ROFECOXIB: Safety Overview

Metric RITUXIMAB-PVVR ROFECOXIB
Total FAERS Reports 4,210 1,238
Deaths Reported 415 56
Death Rate 9.9% 4.5%
Hospitalizations 966 176
Average Patient Age 60.4 yrs 63.1 yrs
% Female Patients 67.9% 77.9%
FDA Approval Date N/A Feb 25, 2000
Marketing Status Prescription Discontinued